In PCI-treated ACS, switching from aspirin + a newer P2Y12 blocker to aspirin + clopidogrel reduced adverse events.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Lowenstern, A; Newby, LK

Published Date

  • September 19, 2017

Published In

Volume / Issue

  • 167 / 6

Start / End Page

  • JC28 -

PubMed ID

  • 28975318

Pubmed Central ID

  • 28975318

Electronic International Standard Serial Number (EISSN)

  • 1539-3704

Digital Object Identifier (DOI)

  • 10.7326/ACPJC-2017-167-6-028

Language

  • eng

Conference Location

  • United States